CIZ - Ticker AI Digest

Cizzle Biotechnology Holdings PLC 📰 1
TradingFloor AI GO VIP Login

Digested News

Today's Catalysts (CIZ) 1
CIZ 10:19
Cizzle Biotechnology Holdings PLC
Final results for the year ended 31 December 2024
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 0
No items for this category on selected date.
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 1
CIZ 09:01
Cizzle Biotechnology Holdings PLC
Launch of New Website
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
Cizzle Biotechnology Holdings plc, a UK-based diagnostics company, has launched a new corporate website: https://cizzlebiotechnology.com. The website will provide stakeholders, shareholders, investors, and customers with access to a range of information and news about the company and its products. Cizzle Biotechnology is focused on finalizing regulatory and launch plans in the USA for its non-invasive, cost-effective blood <mark style="background-color:yellow">test</mark>, the CIZ1B Biomarker test, which aids in the early detection of lung cancer. The new website is part of the companys enhanced communication strategy to support its global growth initiatives.
Key Personnel
Allan SymsExecutive ChairmanCizzle Biotechnology Holdings plc
John Depasquale/Piers ShimwellCorporate FinanceAllenby Capital Limited
Stefano Aquilino/Amrit NahalSales and Corporate BrokingAllenby Capital Limited
Tim Metcalfe/Florence ChandlerIFC Advisory Limited
This announcement is distributed by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange.
Litigation 0
No items for this category on selected date.
NewContract 1
CIZ 06:01
Cizzle Biotechnology Holdings PLC
Contract in Caribbean and Update on CIZ1B
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 1
CIZ 10:19
Cizzle Biotechnology Holdings PLC
Final results for the year ended 31 December 2024
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 0
No items for this category on selected date.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 3
CIZ 10:19
Cizzle Biotechnology Holdings PLC
Final results for the year ended 31 December 2024
CIZ 06:01
Cizzle Biotechnology Holdings PLC
Contract in Caribbean and Update on CIZ1B
CIZ 09:01
Cizzle Biotechnology Holdings PLC
Launch of New Website
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
Cizzle Biotechnology Holdings plc, a UK-based diagnostics company, has launched a new corporate website: https://cizzlebiotechnology.com. The website will provide stakeholders, shareholders, investors, and customers with access to a range of information and news about the company and its products. Cizzle Biotechnology is focused on finalizing regulatory and launch plans in the USA for its non-invasive, cost-effective blood <mark style="background-color:yellow">test</mark>, the CIZ1B Biomarker test, which aids in the early detection of lung cancer. The new website is part of the companys enhanced communication strategy to support its global growth initiatives.
Key Personnel
Allan SymsExecutive ChairmanCizzle Biotechnology Holdings plc
John Depasquale/Piers ShimwellCorporate FinanceAllenby Capital Limited
Stefano Aquilino/Amrit NahalSales and Corporate BrokingAllenby Capital Limited
Tim Metcalfe/Florence ChandlerIFC Advisory Limited
This announcement is distributed by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange.

AI Crunch

Single-Ticker AI Crunch
CIZ signal theatre built from scored market catalysts, automated AI forecasts, and live trigger logic.

This is the ticker-specific AI Crunch desk for Cizzle Biotechnology Holdings PLC. It compresses bullish and bearish catalyst scoring, best and worst AI forecast paths, and automated buy or sell trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI Forecast Stack Buy / Sell Trigger Engine Catalyst Ledger
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full CIZ AI Crunch cockpit.

Subscription turns this tab into a live signal desk with bullish vs bearish machine scoring, AI forecast stack comparisons, buy and sell trigger logic, and the full catalyst ledger behind every scored catalyst row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific signal stack, sentiment gauges, forecast stage, and the full catalyst ledger for CIZ on 2025-04-30.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
8799898
Enterprise Value
4731758
Public Float
75.9
Broker Target
-
Shares Out
396391773
Long Interest
-
Short Interest
-
Exchange
LSE
Currency Code
GBX
ISIN
GB00BNG2VN02
Market
None
Sector
Pharmaceuticals and Biotechnology
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
2009-01-01
Earnings Date
2025-09-25
Net Debt
-365000.0
Cash
365000.0
EPS
-
Net Income
-2166.0
Revenue
-
Enterprise Value
4731758
Trailing PE
-
Forward PE
-
Price Sales TTM
200.4826
Price Book MRQ
5.2607
EV Revenue
-
EV EBITDA
-8.6203

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
11.14
Institutions As Of
2025-05-28
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
0
Sale Director Dealing
0
Purchase TR1
1
Sale TR1
0
Broker Coverage Rows
0
Institution Holders Tracked
1
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

Today's Catalysts

1 live catalyst just hit CIZ.

The headlines landing in Digested News are now framed here as today's catalyst tape. Scroll the tab rail to Digested News or jump there instantly below.
Live Tape Data 2025-04-30 AI Charts Landing View
Scroll the tab rail to Digested News any time, or use the jump button to land straight on today's tape.
1 Today
Catalyst Pulse
Cizzle Biotechnology Holdings PLC has fresh news flow feeding the chart narrative.
10:19 Today's Catalyst Final results for the year ended 31 December 2024
AI Charts Studio
CIZ Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2025-04-30 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
TradingFloor AI Member Login
Indicators0
Technicals0
AI Forecast 1.94%
RSI Gauge
Price Change
AI Forecast